- Home
- JYD vs IMCC Comparison
JYD vs IMCC Comparison
Compare JYD & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JYD | IMCC |
|---|---|---|
| Founded | 2001 | 1980 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0M | 10.4M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | JYD | IMCC |
|---|---|---|
| Price | $4.20 | $1.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 77.8K | ★ 127.8K |
| Earning Date | 12-04-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $80,305,742.00 | $37,606,703.00 |
| Revenue This Year | N/A | $47.12 |
| Revenue Next Year | N/A | $12.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1.92 |
| 52 Week Low | $2.71 | $0.93 |
| 52 Week High | $400.00 | $7.12 |
Technical Indicators
Market Signals| Indicator | JYD | IMCC |
|---|---|---|
| Relative Strength Index (RSI) | 56.59 | 56.25 |
| Support Level | $3.96 | $1.65 |
| Resistance Level | $4.74 | $1.84 |
| Average True Range (ATR) | 0.47 | 0.19 |
| MACD | 0.04 | 0.05 |
| Stochastic Oscillator | 73.48 | 85.26 |
Price Performance
Historical ComparisonAbout JYD Jayud Global Logistics Limited
Jayud Global Logistics Ltd is an end-to-end supply chain solution provider in China, with a focus on providing cross-border logistics services. The company offers freight forwarding services, supply chain management, and other value-added services.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.